It has been shown that increased IGF1R signaling was apparent in postmortem brains of Alzheimer’s disease (AD) patients [6], suggesting that a long-term increase in activity is associated with the progression of AD neuropathology. The gene discussed is IGF1R; the disease is Alzheimer disease.